Mice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of tolerance

European Journal of Immunology

Volumn 40, Issue 6, 2010, Pages 1758-1767

  Baruah, Paramita ^a   Simpson, Elizabeth ^a   Dumitriu, Ingrid E ^a   Derbyshire, Katy ^a   Coe, David ^a   Addey, Caroline ^a   Dyson, Julian ^a   Chai, Jian Guo ^a   Cook, Terence ^a   Scott, Diane ^a   Botto, Marina ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Complement; Skin graft; Tolerance

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; GAMMA INTERFERON; HY PEPTIDE; INTERLEUKIN 10; PEPTIDE; TETRAMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; ISOGRAFT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN GRAFT;

ADMINISTRATION, INTRANASAL; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENT C1Q; COMPLEMENT C3; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; H-Y ANTIGEN; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 77953300684     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940158     Document Type: Article

References (39)

1. Kemper, C. and Atkinson, J. P., T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007. 7: 9-18.
2. Kemper, C., Chan, A. C., Green, J. M., Brett, K. A., Murphy, K. M. and Atkinson, J. P., Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003. 421: 388-392.
3. Hammerberg, C., Katiyar, S. K., Carroll, M. C. and Cooper, K. D., Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance. J. Exp. Med. 1998. 187: 1133-1138.
4. Sohn, J. H., Bora, P. S., Suk, H. J., Molina, H., Kaplan, H. J. and Bora, N. S., Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat. Med. 2003. 9: 206-212.
5. Baldwin, W. M., III, Kasper, E. K., Zachary, A. A., Wasowska, B. A. and Rodriguez, E. R., Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection. Am. J. Transplant. 2004. 4: 311-318.
6. Serinsoz, E., Bock,O., Gwinner, W., Schwarz, A., Haller, H., Kreipe, H. and Mengel, M., Local complement C3 expression is upregulated in humoral and cellular rejection of renal allografts. Am. J. Transplant. 2005. 5: 1490-1494.
7. Hart, M. L., Ceonzo, K. A., Shaffer, L. A., Takahashi, K., Rother, R. P., Reenstra, W. R., Buras, J. A. and Stahl, G. L., Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J. Immunol. 2005. 174: 6373-6380. (Pubitemid 40663830)
8. Wada, K., Montalto, M. C. and Stahl, G. L., Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology 2001. 120: 126-133. (Pubitemid 32061876)
9. Pratt, J. R., Basheer, S. A. and Sacks, S. H., Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 2002. 8: 582-587.
10. Walport, M. J., Complement. Second of two parts. N. Engl. J. Med. 2001. 344: 1140-1144.
11. Walport, M. J., Complement. First of two parts. N. Engl. J. Med. 2001. 344: 1058-1066.
12. Baruah, P., Dumitriu, I. E., Malik, T. H., Cook, H. T., Dyson, J., Scott, D., Simpson, E. and Botto, M., C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. Blood 2009. 113: 3485-3493.
13. Baruah, P., Dumitriu, I. E., Peri, G., Russo, V., Mantovani, A., Manfredi, A. A. and Rovere-Querini, P., The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J. Leukoc. Biol. 2006. 80: 87-95.
14. Peng, Q., Li, K., Anderson, K., Farrar, C. A., Lu, B., Smith, R. A., Sacks, S. H. and Zhou, W., Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 2008. 111: 2452-2461.
15. Peng, Q., Li, K., Patel, H., Sacks, S. H. and Zhou, W., Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J. Immunol. 2006. 176: 3330-3341. (Pubitemid 43363979)
16. La Flamme, A. C., MacDonald, A. S., Huxtable, C. R., Carroll, M. and Pearce, E. J., Lack of C3 affects Th2 response development and the sequelae of chemotherapy in schistosomiasis. J. Immunol. 2003. 170: 470-476. (Pubitemid 36026173)
17. Marsh, J. E., Farmer, C. K., Jurcevic, S., Wang, Y., Carroll, M. C. and Sacks, S. H., The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation 2001. 72: 1310-1318. (Pubitemid 33026614)
18. Botto, M., Dell'Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P. et al., Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 1998. 19: 56-59.
19. Hurme, M., Chandler, P. R., Hetherington, C. M. and Simpson, E., Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts. J. Exp. Med. 1978. 147: 768-775.
20. Hurme, M., Hetherington, C. M., Chandler, P. R. and Simpson, E., Cytotoxic T-cell responses to H-Y: mapping of the Ir genes. J. Exp. Med. 1978. 147: 758-767.
21. Gordon, R. D., Simpson, E. and Samelson, L. E., In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice. J. Exp. Med. 1975. 142: 1108-1120.
22. Eichwald, E. J. and Silmser, C. R., Skin. Transplant. Bull. 1955. 2: 148-149.
23. Zelenika, D., Adams,E.,Mellor, A., Simpson, E., Chandler, P., Stockinger, B., Waldmann, H. and Cobbold, S. P., Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J. Immunol. 1998. 161: 1868-1874. (Pubitemid 28387608)
24. Chai, J. G., James, E., Dewchand, H., Simpson, E. and Scott, D., Transplantation tolerance induced by intranasal administration of HY peptides. Blood 2004. 103: 3951-3959.
25. Botto, M. and Walport, M. J., C1q, autoimmunity and apoptosis. Immunobiology 2002. 205: 395-406.
26. Pickering, M. C., Botto, M., Taylor, P. R., Lachmann, P. J. and Walport, M. J., Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 2000. 76: 227-324.
27. Leventhal, J. R., Dalmasso, A. P., Cromwell, J.W., Platt, J. L., Manivel, C. J., Bolman, R. M., III and Matas, A. J., Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993. 55: 857-865; discussion 865-866.
28. Wang, C., Li, J., Cordoba, S. P., McLeod, D. J., Tran, G. T., Hodgkinson, S. J., Hall, B. M., McCaughan, G. W. et al., Posttransplant interleukin-4 treatment converts rat liver allograft tolerance to rejection. Transplantation 2005. 79: 1116-1120.
29. Simpson, E., Scott, D., James, E., Lombardi, G., Cwynarski, K., Dazzi, F., Millrain, M. and Dyson, P. J., Minor H antigens: genes and peptides. Transplant. Immunol. 2002. 10: 115-123.
30. Csencsits, K., Burrell, B. E., Lu, G., Eichwald, E. J., Stahl, G. L. and Bishop, D. K., The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy. Am. J. Transplant. 2008. 8: 1622-1630.
31. Konieczny, B. T., Dai, Z., Elwood, E. T., Saleem, S., Linsley, P. S., Baddoura, F. K., Larsen, C. P. et al., IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol. 1998. 160: 2059-2064. (Pubitemid 28119882)
32. Sawitzki, B., Kingsley, C. I., Oliveira, V., Karim, M., Herber, M. and Wood, K. J., IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 2005. 201: 1925-1935.
33. Kitching, A. R., Turner, A. L., Semple, T., Li,M., Edgtton, K. L., Wilson, G. R., Timoshanko, J. R. et al., Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-gamma. J. Am. Soc. Nephrol. 2004. 15: 1764-1774.
34. Munn, D. H. and Mellor, A. L., Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 2007. 117: 1147-1154.
35. Daniel, D. and Wegmann, D. R., Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA 1996. 93: 956-960.
36. Hoyne, G. F., Askonas, B. A., Hetzel, C., Thomas, W. R. and Lamb, J. R., Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int. Immunol. 1996. 8: 335-342.
37. Millrain, M., Chandler, P., Dazzi, F., Scott, D., Simpson, E. and Dyson, P. J., Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis. J. Immunol. 2001. 167: 3756-3764. (Pubitemid 32910821)
38. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. and Davis, M. M., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.
39. Millrain, M., Scott, D., Addey, C., Dewchand, H., Ellis, P., Ehrmann, I., Mitchell, M. et al., Identification of the immunodominant HY H2-D(k) epitope and evaluation of the role of direct and indirect antigen presentation in HY responses. J. Immunol. 2005. 175: 7209-7217. (Pubitemid 41713415)